Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immune Reset to Allow Access to Hla-compatible Kidney Transplantation in Hyperimmunized Patients

NCT07607197 is registered in ClinicalTrials.gov with Hospital Universitari Vall d'Hebron Research Institute as lead sponsor.

NCT NCT07607197
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07607197 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immune Reset to Allow Access to Hla-compatible Kidney Transplantation in Hyperimmunized Patients
Lead sponsor
Hospital Universitari Vall d'Hebron Research Institute
Phase
Phase 1/2
Overall status
Recruiting
Start date
February 1, 2024
Completion date
June 30, 2028
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alloimmunization, end stage cronic kidney disease, highly sensitized patients awaiting kidney transplant, hla sensitization, kidney failure, chronic, kidney transplantation